𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inorganic pyrophosphatase as a label in heterogeneous enzyme immunoassay

✍ Scribed by A.A. Baykov; V.N. Kasho; S.M. Avaeva


Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
475 KB
Volume
171
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.

✦ Synopsis


Inorganic pyrophosphatase from Escherichia coli has been employed as a label in heterogeneous enzyme immunoassays. Enzyme-antibody conjugates were prepared with the use of glutaraldehyde and purified by gel permeation chromatography. Enzyme activity was measured by means of a sensitive one-step color reaction between phosphate, molybdate, and malachite green. The sensitivity in terms of absorbance readings was four to eight times higher than that of peroxidase-based assays. The color change (yellow to greenish blue) inherent in the use of pyrophosphatase as the labeling agent is highly suitable for visual analysis. Other merits of pyrophosphatase include the remarkable stability of the enzyme and its substrate, its compatibility with bacteriostatic agents, and its low Michaelis constant. Examples of the use of phosphatase in the assay of human alpha-fetoprotein and immunoglobulin G are presented.


📜 SIMILAR VOLUMES


Chemiluminescent labelled streptavidin (
✍ Strasburger, C. J. ;Kohen, F. 📂 Article 📅 1989 🏛 John Wiley and Sons ⚖ 543 KB

The tetrameric structure of streptavidin and its exceptionally strong affinity t o biotin (K, = IOl5M-') can be exploited t o achieve an amplification of the signal in immunoassays. In the approach described here streptavidin (STAV) labelled with aminobutylethyl-isoluminol (ABEI) served as a univers

Plasma level monitoring of nasal salmon
✍ Hiromichi Nakamuta; Takeyuki Kohno; Masaki Ichikawa; Takashi Hoshino; Kazuhito W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

The experimental and clinical effectiveness of nasal salmon calcitonin (SCT) for treatment of osteoporosis in humans has been well established, but none is known yet about the pharmacokinetic property in relation to therapeutic efficacy, especially when used in a therapeutic dose range. This preclin

Chemiluminescent enzyme immunoassay for
✍ Arakawa, H. ;Ikegami, T. ;Maeda, M. ;Tsuji, A. 📂 Article 📅 1993 🏛 John Wiley and Sons ⚖ 296 KB

## Abstract We developed a sensitive chemiluminescent sandwich‐type enzyme immunoassay (CLEIA) of alpha‐fetoprotein (AFP) using b̃‐D‐galactosidase (b̃‐gal) as a label and 5‐bromo‐4‐chloro‐3‐indolyl‐b̃‐D‐galactopyranoside as a substrate. The CL‐EIA for AFP was performed using two monoclonal antibodi

Typing of human group A rotavirus with a
✍ Warawadee Nirdnoy; Orntipa Sethabutr; Thamma Sakulkaipeara; Charles W. Hoge; Pet 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB

Monoclonal antibodies (MAbs) to serotype specific antigens have been isolated and used to define each of these proteins separately. In this study, G types were identified by surface antigens or

Measurement of Urinary F2-Isoprostanes a
✍ Julie Proudfoot; Anne Barden; Trevor A. Mori; Valerie Burke; Kevin D. Croft; Law 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 92 KB

This study aimed at comparing the two most commonly utilized methods for measuring urinary F 2 -isoprostanes, currently considered one of the best available markers of in vivo lipid peroxidation. The F 2isoprostanes were measured in 24-h urine samples from 14 male subjects using electron capture neg